494 related articles for article (PubMed ID: 31077733)
1. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
2. Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil.
Silva LA; Reis-Cunha JL; Bartholomeu DC; Vítor RW
PLoS One; 2017; 12(1):e0170689. PubMed ID: 28118394
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo susceptibility to sulfadiazine and pyrimethamine of Toxoplasma gondii strains isolated from Brazilian free wild birds.
de Lima Bessa G; Vitor RWA; Lobo LMS; Rêgo WMF; de Souza GCA; Lopes REN; Costa JGL; Martins-Duarte ES
Sci Rep; 2023 May; 13(1):7359. PubMed ID: 37147353
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil.
Alves CF; Vitor RW
Parasite; 2005 Jun; 12(2):171-7. PubMed ID: 15991831
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
Martins-Duarte ÉS; de Souza W; Vommaro RC
Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
[TBL] [Abstract][Full Text] [Related]
6. Pathological changes in acute experimental toxoplasmosis with Toxoplasma gondii strains obtained from human cases of congenital disease.
Pinheiro BV; Noviello Mde L; Cunha MM; Tavares AT; Carneiro AC; Arantes RM; Vitor RW
Exp Parasitol; 2015 Sep; 156():87-94. PubMed ID: 26072201
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.
Meneceur P; Bouldouyre MA; Aubert D; Villena I; Menotti J; Sauvage V; Garin JF; Derouin F
Antimicrob Agents Chemother; 2008 Apr; 52(4):1269-77. PubMed ID: 18212105
[TBL] [Abstract][Full Text] [Related]
8. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ
Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations.
de Lima Bessa G; de Almeida Vitor RW; Dos Santos Martins-Duarte E
Parasitol Res; 2021 Sep; 120(9):3065-3076. PubMed ID: 34390383
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Romand S; Pudney M; Derouin F
Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
[TBL] [Abstract][Full Text] [Related]
11. Sulfadiazine Sodium Ameliorates the Metabolomic Perturbation in Mice Infected with Toxoplasma gondii.
Zhou CX; Gan Y; Elsheikha HM; Chen XQ; Cong H; Liu Q; Zhu XQ
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383652
[TBL] [Abstract][Full Text] [Related]
12. Effect of Nigella sativa oil on experimental toxoplasmosis.
Mady RF; El-Hadidy W; Elachy S
Parasitol Res; 2016 Jan; 115(1):379-90. PubMed ID: 26446086
[TBL] [Abstract][Full Text] [Related]
13. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
[TBL] [Abstract][Full Text] [Related]
14. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
Araujo FG; Lin T; Remington JS
J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
[TBL] [Abstract][Full Text] [Related]
15. Congenital human toxoplasmosis caused by non-clonal Toxoplasma gondii genotypes in Argentina.
Pardini L; Bernstein M; Carral LA; Kaufer FJ; Dellarupe A; Gos ML; Campero LM; Moré G; Messina MT; Schneider MV; Freuler CB; Durlach RA; Unzaga JM; Venturini MC
Parasitol Int; 2019 Feb; 68(1):48-52. PubMed ID: 30304711
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Efficacy of Drugs against Toxoplasma gondii Combined with Immunomodulators.
Köksal ZŞ; Yanik K; Bilgin K; Yılmaz EM; Hokelek M
Jpn J Infect Dis; 2016; 69(2):113-7. PubMed ID: 26166498
[TBL] [Abstract][Full Text] [Related]
17. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
Portes JA; De Souza W
Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
[TBL] [Abstract][Full Text] [Related]
18. Tissue dissemination and humoral response after experimental reinfection with atypical Toxoplasma gondii strains obtained from congenital human toxoplasmosis in Brazil.
Bessa GL; Costa JGL; Rêgo WMF; Baraviera RCA; Pinto LV; Lopes REN; Vitor RWA
Exp Parasitol; 2019 Dec; 207():107781. PubMed ID: 31626796
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.
Nguyen BT; Stadtsbaeder S
Br J Pharmacol; 1983 Aug; 79(4):923-8. PubMed ID: 6606459
[TBL] [Abstract][Full Text] [Related]
20. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]